Multiple Sclerosis (The ^AFacts Series)

Amor, Sandra; Van Noort, Hans

ISBN 10: 0199652570 / ISBN 13: 9780199652570

Published by Oxford University Press, 2012

About this Item

Seller Inventory # U9780199652570

Bibliographic Details

• Title: Multiple Sclerosis (The ^AFacts Series)
• Publisher: Oxford University Press
• Publication Date: 2012
• Language: English
• ISBN 10: 0199652570
• ISBN 13: 9780199652570
• Binding: Soft cover
• Edition: 1787327493.
• Condition: Very Good
• Dust Jacket Condition: 11208662
• Signed: 8/21/2026 3:51:33 PM
• Seller catalogs:
  • 1
  • U
  • 9780199652570

About this title

Synopsis

Multiple Sclerosis: The Facts addresses the most frequently asked questions on MS, and provides answers in an easy to read and accessible format including an explanation of the disease process, symptoms and diagnosis, and how drugs and alternative approaches work.

About the Author

Sandra Amor obtained her PhD in Pathology at London University, UK in 1988, specialising in virus infections of the central nervous system. After her PhD she established a research group at St Thomas's Hospital examining how autoimmune responses to brain proteins are involved in multiple sclerosis. Her research expanded and after a few years in neurosciences at Imperial College she moved to the Netherlands where she became Head of Autoimmunity at a Research Institute in Rijswijk. In 2007, Sandra Amor moved her research back into human pathology at the Free University in Amsterdam. As Head of Multiple Sclerosis Research in the Pathology Department her group specialises in examining the very first steps in the formation of damage in MS brains. She also has a honorary position at Blizard Institute, Barts and The London Hospital, London UK.


After obtaining his PhD in biochemistry at the University of Leiden in 1985, The Netherlands, and working at the research center of Hoffman La Roche in Nutley, NJ, Hans van Noort joined the research organisation TNO in the Netherlands. He started his multiple sclerosis research in 1992, which led him to the identification of the small heat shock protein alpha B-crystallin as a major myelin-associated target for human T cells. In 2008, he co-founded the biotechnology company Delta Crystallon BV and now leads it research efforts as chief scientific officer, aiming at the clinical development of alpha B-crystallin as a novel therapeutic protein for MS and other inflammatory disorders.